A Phase I Study of AZD4635 in Japanese Patients with Advanced Solid Malignancies

Trial Identifier: D8730C00005
Sponsor: AstraZeneca
NCTID:: NCT03980821
Start Date: July 2019
Primary Completion Date: September 2020
Study Completion Date: September 2020
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Japanese Translation

Trial Locations

Country Location
Japan Chuo-ku, Japan, 104-0045
Japan Kashiwa, Japan, 277-8577